ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,884Medicare Part D Prescriptions Filled, Including Refills

Rank: 44 out of 1031

$1.23M Total Retail Price of All Prescriptions

Rank: 44 out of 1031

704 Patients Receiving at Least One Drug in Part D
66% Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Alabama
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

4% of this provider’s 704 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

18% of this provider’s 704 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Alabama
POTASSIUM CHLORIDE 1,051 796 154 1 13
SIMVASTATIN 985 825 150 2 4
LISINOPRIL 847 632 120 3 6
AMLODIPINE BESYLATE 839 713 108 4 5
FUROSEMIDE 816 663 133 5 7
HYDROCHLOROTHIAZIDE 766 536 127 6 14
OMEPRAZOLE 702 495 122 7 2
CRESTOR 581 396 87 8 36
METFORMIN HCL 553 358 94 9 8
WARFARIN SODIUM 499 467 50 10 27
HYDROCODONE-ACETAMINOPHEN 494 292 117 S3 11 1
CARVEDILOL 474 392 73 12 17
LEVOTHYROXINE SODIUM 467 389 70 13 3
NAMENDA 413 413 53 14 45
ATORVASTATIN CALCIUM 399 307 68 15 9
GABAPENTIN 366 290 63 16 11
CITALOPRAM HBR 346 320 53 17 18
DONEPEZIL HCL 343 324 46 18 41
ATENOLOL 323 231 47 19 28
NAMENDA XR 318 318 37 10 20 291
GLYBURIDE 303 212 51 R 21 121
ALLOPURINOL 302 239 47 22 35
ZETIA 253 209 29 23 78
TRAZODONE HCL 247 212 44 24 32
CLONIDINE HCL 243 161 40 25 34
TRAMADOL HCL 240 200 73 26 15
CLOPIDOGREL 236 213 37 27 25
MELOXICAM 233 176 52 28 16
LOVASTATIN 226 178 32 29 52
METOPROLOL TARTRATE 222 163 34 30 22
PRAVASTATIN SODIUM 215 115 39 31 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 204 186 32 32 23
ESCITALOPRAM OXALATE 200 166 28 33 43
QUETIAPINE FUMARATE 195 190* 28 A 34 60
PANTOPRAZOLE SODIUM 191 160 26 35 24
MONTELUKAST SODIUM 191 123 40 35 38
AZITHROMYCIN 175 125 135 37 46
RAMIPRIL 161 112 24 38 79
ALENDRONATE SODIUM 154 149* 25 39 65
LORAZEPAM 152 109 34 B 40 31
WELCHOL 149 109 21 41 237
NEXIUM 146 80 22 42 26
LOSARTAN POTASSIUM 134 110 20 43 19
PIOGLITAZONE HCL 133 90 18 R 44 93
METOPROLOL SUCCINATE 133 100 22 44 21
JANUVIA 130 79 24 46 72
HYDRALAZINE HCL 129 114 22 47 75
SERTRALINE HCL 123 96 19 48 30
SULFAMETHOXAZOLE-TRIMETHOPRIM 119 79 87 49 69
FLUCONAZOLE 118 82 54 50 102
POLYETHYLENE GLYCOL 3350 116 69 29 51 82
ULORIC 115 75 15 52 303
LOSARTAN-HYDROCHLOROTHIAZIDE 114 95 14 53 37
ZOLPIDEM TARTRATE 114 65 27 53 20
FELODIPINE ER 114 103 12 53 204
FLUTICASONE PROPIONATE 113 65 44 56 39
EXELON 107 102* 30 57 116
TRIAMTERENE-HCTZ 100 80 17 58 57
LANTUS 98 93* 21 59 85
CYCLOBENZAPRINE HCL 96 42 38 R 60 51
DIGOX 95 83 16 61 103
TAMSULOSIN HCL 94 68 16 62 33
GLIMEPIRIDE 93 62 11 63 40
VERAPAMIL ER 93 77 14 63 96
DILTIAZEM 24HR ER 90 90 15 65 145
CIPROFLOXACIN HCL 84 55 62 66 53
IBUPROFEN 82 50 23 67 99
MIRTAZAPINE 81 81 13 68 59
GENERLAC 80 49 22 69 231
DEXAMETHASONE SODIUM PHOSPHATE* 80 75* 23 69 338
LEVOFLOXACIN 79 61 61 71 58
CLONAZEPAM 78 55 19 B 72 29
LEVETIRACETAM 75 <11 <11 73 126
LYRICA 75 <11 <11 73 49
ENALAPRIL MALEATE 74 40 16 75 66
SPIRONOLACTONE 74 33 14 75 77
PROAIR HFA 73 40 22 77 42
ALPRAZOLAM 72 46 18 B 78 12
TRIAMTERENE-HYDROCHLOROTHIAZID 72 <11 <11 78 206
PHENYTOIN SODIUM EXTENDED 71 <11 <11 80 131
PREDNISONE 69 <11 <11 81 47
AVODART 69 <11 <11 81 199
GLIPIZIDE 67 47 14 83 63
BYSTOLIC 65 <11 <11 84 125
NYSTATIN-TRIAMCINOLONE 65 60* 29 84 308
RIVASTIGMINE 64 64 12 86 235
AMOXICILLIN 62 39 47 87 87
ONGLYZA 62 <11 <11 87 208
FAMOTIDINE* 61 <11 <11 89 95
CYMBALTA 60 <11 <11 90 50
AMITRIPTYLINE HCL 59 42 11 R 91 54
DETROL LA 58 <11 <11 92 185
BUSPIRONE HCL 58 45 12 92 107
PROMETHAZINE HCL 58 35 28 R 92 67
TAZTIA XT 57 <11 <11 95 359
VYTORIN 57 <11 <11 95 198
RISPERIDONE 55 <11 <11 A 97 100
LOVAZA 55 <11 <11 97 140
ISOSORBIDE MONONITRATE ER 54 <11 <11 99 80
METHYLPREDNISOLONE 53 33 48 100 98
NOVOLOG FLEXPEN 52 34 13 101 251
VALACYCLOVIR 52 <11 <11 101 341
FENTANYL 52 47* 12 S2 101 108
OLANZAPINE 51 <11 <11 A 104 184
AMLODIPINE BESYLATE-BENAZEPRIL 50 <11 <11 105 62
ROZEREM 50 <11 <11 105 474
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.